CTOs on the Move


 
Ipsos is one of the largest market research and polling companies globally, operating in 90 markets and employing over 18,000 people. Our passionately curious research professionals, analysts and scientists have built unique multispecialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques. Our tagline "Game Changers" sums up our ambition to help our 5,000 customers move confidently through a rapidly changing world. Founded in France in 1975, Ipsos has been listed on ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.ipsos.com
  • 180 Madison Avenue 22nd Floor
    New York, NY USA 10016
  • Phone: 212.265.3200

Executives

Name Title Contact Details
Tom Juetten
Executive Vice President of United States Innovation Practice and Service Line Lead Profile
Chris Chowaniec
Chief Technology Officer, CX Technologist Profile

Similar Companies

Mc Cann Erickson Inc

Mc Cann Erickson Inc is a San Francisco, CA-based company in the Business Services sector.

Celltech Labs

Celltech Labs Inc. is a Kelowna, BC-based company in the Business Services sector.

Phygen Inc

Phygen Inc is a Minneapolis, MN-based company in the Business Services sector.

Fossick Project

Fossick Project is a contemporary shadow theatre show that explores the wonders of our planet through illustration, animation, and music.

Anterios

Anterios is a privately held, clinical-stage biopharmaceutical company that is developing next-generation botulinum-based prescription products for medical dermatology and aesthetic medicine. Anterios has developed NDSTM, a proprietary platform technology that enables local, targeted delivery of botulinum toxin and other macromolecules across the skin without needles or other invasive treatments that can be destructive to the skin. NDS also enables the formulation of macromolecules as ready-to-use liquid injectable products. In the future, Anterios plans to develop additional dermatology products to topically deliver active ingredients other than botulinum, as well as formulate additional injectable products that require deeper delivery.